Georg Lenz

23PUBLICATIONS
208CO-AUTHORS
Biomechanical engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cellular immunologyTransplantation immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 01, 2026
Feasibility and safety of rapid glofitamab ramp-up.

|Jun 02, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

|Mar 26, 2026
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma.

Felix Czernilofsky, Anna Mathioudaki, Lea Jopp-Saile

|Aug 22, 2025
Immune reconstitution in AML and MDS patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) with treosulfan- or TBI-based conditioning.

Lina Kolloch, Philipp Berning, Jörn C Albring

|Jul 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.

Julian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch

|Nov 05, 2024
Real world outcome analysis of treosulfan-based conditioning prior to allo-HCT in patients with MDS compared to clinical trial data.

Matthias Stelljes, Katja Sockel, Matthias Floeth

Pageof 4

Frequent Collaborators

5 joint publications

Matthias Stelljes

4 joint publications

Fabian Frontzek

4 joint publications

Christoph Schliemann

4 joint publications

Philipp Berning